ADNPX
Price
$15.96
Change
+$0.23 (+1.46%)
Updated
Jan 17 closing price
Net Assets
190.83M
RRMGX
Price
$90.18
Change
+$0.33 (+0.37%)
Updated
Jan 17 closing price
Net Assets
30.69B
Ad is loading...

ADNPX vs RRMGX

Header iconADNPX vs RRMGX Comparison
Open Charts ADNPX vs RRMGXBanner chart's image
American Beacon ARK Transfmt Innov I
Price$15.96
Change+$0.23 (+1.46%)
VolumeN/A
Net Assets190.83M
T. Rowe Price Mid-Cap Growth R
Price$90.18
Change+$0.33 (+0.37%)
VolumeN/A
Net Assets30.69B
ADNPX vs RRMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ADNPX vs. RRMGX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNPX is a Hold and RRMGX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 30.7B vs. ADNPX (191M). ADNPX (0.00) and RRMGX (0.00) have matching dividends . ADNPX was incepted earlier than RRMGX: ADNPX (8 years) vs RRMGX (22 years). ADNPX is a more actively managed with annual turnover of: 33.00 vs. RRMGX (21.70). ADNPX (2500) and RRMGX (2500) have matching initial minimum investment requirements. ADNPX annual gain was more profitable for investors over the last year : 30.18 vs. RRMGX (1.36). RRMGX return over 5 years is better than : -1.57 vs. ADNPX (-18.88).
ADNPXRRMGXADNPX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD5.0002.571195%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets191M30.7B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year30.181.362,219%
Returns for 3 years-28.62-6.88416%
Returns for 5 years-18.88-1.571,201%
Returns for 10 yearsN/A27.05-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAY69.62-0.56
-0.80%
Dayforce
HUMA4.41-0.07
-1.56%
Humacyte
TIXT3.55-0.09
-2.47%
TELUS International (Cda)
TCBP0.38-0.01
-3.61%
TC BioPharm (Holdings) plc
RENB0.71-0.04
-5.73%
Renovaro